Characteristics of quinolone-induced small colony variants in Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 697-705

  Mitsuyama, Junichi ^a   Yamada, Hisashi ^a   Maehana, Junko ^a   Fukuda, Yoshiko ^a   Kurose, Sumiko ^a   Minami, Shinzaburo ^a   Todo, Yozo ^a   Watanabe, Yasuo ^a   Narita, Hirokazu ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOXAZINE DERIVATIVE; CARBON; CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); NAPHTHYRIDINE DERIVATIVE; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; VERAPAMIL;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM COLONY; CONTROLLED STUDY; CULTURE MEDIUM; GENE MUTATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERMEABILITY; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DNA PRIMERS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; MALE; MICE; MICE, INBRED ICR; OXAZINES; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030875684     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.697     Document Type: Article

References (33)

1. Lyon, B. R. & Skurray, R. (1987). Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiological Review 51, 88-134.
2. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T. et al. (1980). In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 17, 103-8.
3. Shalit, I., Berger, S. A., Gorea, A. & Frimerman, H. (1989). Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrobial Agents and Chemotherapy 33, 593-4.
4. Schaefler, S. (1989). Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. Journal of Clinical Microbiology 27, 335-6.
5. Trucksis, M., Hooper, D. C. & Wolfson, J. S. (1991). Emerging resistance to fluoroquinolones in staphylococci: an alert. Annals of Internal Medicine 114, 424-6.
6. Wadsworth, S. J., Kim, K. H., Satishchandran, V., Axelrod, P., Truant, A. L. & Sun, B. (1992). Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 30, 821-6.
7. Fass, R. J., Barnishan, J. &. Ayres, L. W. (1995). Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital. Journal of Antimicrobial Chemotherapy 36, 343-53.
8. Fukuoka, Y., Ikeda, Y., Yamashiro, Y., Takahata, M., Todo, Y. & Narita, H. (1993). In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrobial Agents and Chemotherapy 37, 384-92.
9. Muratani, T., Inoue, M, & Mitsuhashi, S. (1992). In vitro activity of T-3761, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 36, 2293-303.
10. Proctor, R. A., Balwit, J. M. & Vesga, O. (1994). Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infectious Agents and Disease 3, 302-12.
11. Iordanescu, S. & Surdeanu, M. (1976). Two restriction and modification systems in Staphylococcus aureus NCTC8325. Journal of General Microbiology 96, 277-81.
12. Margerrison, E. E., Hopewell, R. & Fisher, L. M. (1992). Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. Journal of Bacteriology 174, 1596-603.
13. Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A. et al. (1994). Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Molecular Microbiology 13, 641-53.
14. Rosenberg, M., Gutnick, D. & Rosenberg, E. (1980). Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiology Letters 9, 29-33.
15. Cohen, S. P., Hooper, D. C., Wolfson, J. S., Souza, K. S., McMurray, L. M. & Levy, S. B. (1988). Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrobial Agents and Chemotherapy 32, 1187-91.
16. Neyfakh, A. A., Borsch, C. M. & Kaatz, G. W. (1993). Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrobial Agents and Chemotherapy 37, 128-9.
17. Barry, A. L., Pfaller, M. A. & Fuchs, P. C. (1992). Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temofloxacin. European Journal of Clinical Microbiology & Infectious Diseases 11, 243-6.
18. Fung-Tomc, J. C. (1990). Correlation of in vitro and in vivo resistance development to antimicrobial agents. Antimicrobial News Letter 7, 17-24.
19. Hori, S., Ohshita, Y., Utsui, Y. & Hiramatsu, K. (1993). Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 37, 2278-84.
20. Ball, P. (1990). Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. Journal of Antimicrobial Chemotherapy 26, Suppl. F, 165-79.
21. Mulligan, M. E., Ruane, P. J., Johnston, L., Wong, P., Wheelock, J. P., MacDonald, K. et al. (1987). Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. American Journal of Medicine 82, Suppl. 4A, 215-9.
22. Peterson, L. R., Quick, J. N., Jensen, B., Homann, S., Johnson, S., Tenquist, J. et al. (1990). Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonization. Archives of Internal Medicine 150, 2151-5.
23. Tankovic, J., Desplaces, N., Duval, J. & Courvalin, P. (1994). In vivo selection during pefloxacin therapy of a mutant of Staphylococcus aureus with two mechanisms of fluoroquinolone resistance. Antimicrobial Agents and Chemotherapy 38, 1149-51.
24. Fasching, C. E., Tenover, F. C., Slama, T. G., Fisher, L. M., Sreedharan, S., Qram, M. et al. (1991). gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. Journal of Infectious Diseases 164, 976-9.
25. Goswitz, J. J., Willard, K. E., Fasching, C. E. & Peterson, L. R. (1992). Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrobial Agents and Chemotherapy 36, 1166-9.
26. Sreedharan, S., Oram, M., Jensen, B., Peterson, L. R. & Fisher, L. M. (1990). DNA gyrase mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. Journal of Bacteriology 172, 7260-2.
27. Sreedharan, S., Peterson, L. R. & Fisher, L. M. (1991). Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 35, 2151-4.
28. Ng, E. Y., Trucksis, M. & Hooper, D. C. (1994). Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrobial Agents and Chemotherapy 33, 1345-55.
29. Kaatz, G. W., Seo, S. M. & Ruble, C. A. (1993). Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 37, 1086-94.
30. Neyfakh, A. A. (1992). The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrobial Agents and Chemotherapy 36, 484-5.
31. Ohshita, Y., Hiramatsu, K. & Yokota, T. (1990). A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus. Biochemical and Biophysical Research Communications 172, 1028-34.
32. Yosida, H., Bogaki, M., Nakamura, S., Ubukata, K. & Konno, M. (1990). Nucleotide sequence and characterization of the Staphylococcus aureus, norA gene, which confers resistance to quinolones. Journal of Bacteriology 172, 6942-9.
33. Kokei, T., Demachi, K. & Tsubokawa, N. (1995). Chemical structure and physicochemical properties of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1, 2,3-de] [1,4]benzoxazine-6-carboxylic acid (T-3761). lyakuhin Kenkyu 26, 211-22.